Answers are grounded in this paper and cite their sources.
Polylactide (PL) co-polymers substituted with pendant azide groups (azido-PL) were synthesized by the nucleophilic conjugate addition of 3-azido-1-propanethiol to a co-polymer of PL containing α,β-unsaturated ester units, poly(lactide- co -methylene glycolide) (ene-PL) that is obtained from the base-promoted dehydrochlorination of poly(lactide- co -chlorolactide) (chloro-PL). Alternatively, azido-PL was prepared by the treatment of chloro-PL with 3-azido-1-propanethiol without isolation of the ene-PL intermediate. The azido-PL was functionalized by copper-catalyzed [3 + 2] cycloaddition reactions with four alkynes: propargyl 4-methoxybenzoate, N, N, N -trimethyl- N -propargylammonium bromide, N, N -dimethyl- N -octyl- N -propargylammonium bromide, and N, N, N -trioctyl- N -propargylammonium bromide. Polymer adducts with N, N, N -trioctyl- N -propargylammonium bromide displayed potent antimicrobial activity both in suspension and as a polymer film.
No takes yet. Share an insight, caveat, or question.
Kalelkar et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: